Partner With Us NRI

Chemcon Speciality Chemicals Ltd share Price

Company details

6M Return 23.57%
1Y Return -37.99%
Mkt Cap.(Cr) 1,029.51
Volume 34,804
Div Yield 1.42%
OI Chg %
Volume 34,804

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Highlights for Q2 FY22:

  • Total Revenue was at Rs. 61.2 Cr
  • EBITDA was at Rs. 18.9 Cr
  • PAT Rs. 14.6 Cr
Commenting on the results, Mr. Kamal Aggarwal, Chairman & MD said, “We are pleased to share that we have delivered another quarter of positive performance as all our key products witnessed robust demand. We have clocked a total operating revenue of Rs 61.2 cr for the quarter. After the backward integration of P7 and P8 unit completed, the HMDS business began operating at full capacity and reported a notable figure for the quarter. On the other hand, Bromide & CMIC business continued to maintain its business momentum.
During the quarter, we were obstructed with an unfortunate external incident. Due to this external incident, GPCB had issued a closure notice which led to production loss. Although, we had 15-20 days of finish goods inventory which had been dispatched to clients on prerequisite schedule and the impact in Q2FY22 was insignificant. The same has been revoked last week and currently, all our facilities are running at full capacity. We are a Zero liquid discharge company and adhere to all best practices require as per global standard. We are a renowned and well-qualified supplier to all major pharmaceutical MNCs. Our operations have continued to operate efficiently and compliantly within the framework for the past two decades.
Expansion of P8 & P9 facilities has been completed and will be ready for a trial run from next week onwards. We expect these units to fully commercialize from Jan-22. We are also delighted to announce that we have initiated the expansion of P10 unit at the same location for other few pharma intermediate products. We are targeting this facility to come onstream by FY23. Our goal is to add more value-added solutions that will help us sustain our business while also allowing us to take new steps forward. We are well positioned to benefit from India's structural position as a leading supplier of chemical products to global MNCs." 



Result PDF

View Other Company Results


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Chemcon Speciality Chemicals Ltd Stocks COMPARISION


Equity Capital: 457.36 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 16,852.71 -20,671.82
LAST 3M 52,922.55 -3,405.64
LAST 6M 58,662.39 139,660.95
LAST 12M 135,235.34 165,245.59

Chemcon Speciality Chemicals Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Chemcon Speciality Chemicals Limited was formerly incorporated as a Private Limited Company with the name `Chemcon Speciality Chemicals Private Limited` in December 15, 1988 and later on, converted to a Public Limited Company effective from 10th April 2019 in Ahemdabad, Gujarat. The Company is into production of pharmaceutical intermediates, Silanes and Oilfield Chemicals (Completion Fluids) industry. The Company is a leading manufacturer of specialized chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC) which are predominantly used in the pharmaceuticals industry and inorganic bromides, predominantly used as completion fluids in the oilfield industry. The Company is one of the reliable partners for completion brines and the largest manufacturer of calcium bromide in India. Its manufacturing plant are located at Manjusar, Vadodara in Gujarat. Within manufacturing facilities, the Company currently has 8 individual operational plants, along with 6 warehouses for storage of products and raw materials. The Company also has an in-house laboratory to test raw materials procured and the products at various stages of the manufacturing process. Information technology provides continuous support to business operations by offering competitive advantages to the Company. A comprehensive ERP system has been implemented, which helps Chemcon increase its supply chain and provides accurate forecasts for sourcing and supply. The IT system and infrastructure are continuously examined and improved with appropriate and timely upgradation. In 1995-1998, the Company made first sale of a few chemical products like Pyridine Hydrobromide, Para Nitro Benzyl Bromide, Methyl Iodide and GA-1. The Company commenced HMDS business in 2001 and discontinued a few products due to lower demand in 2003. In 2005, the Company commenced first export shipment of HMDS Amalgamation of Chemcon Engineers Private Limited with Gujarat Quinone Private Limited and changed the name to `Chemcon Speciality Chemicals Private Limited`. In 2022, the Company has initiated production of CMIC and TMCS at P8 facility at Manjusar. As a result, it has added the production capacity of 2,400 MTPA of TMCS and 1,200 MTPA of CMIC. It is now the largest manufacturer of CMIC in the world with a total capacity of 3,000 MTPA. The Company has started mechanical construction of two more plants at the same location for other pharmaceutical intermediate products.

Registered Address

Block No 355 Manjusar KunpadRd, Manjusar Village Talkua Savli, Vadodara, Gujarat, 391775

Tel : 91-98795 64107
Email : investor.relations:cscpl.com
Website : http://www.cscpl.com

Link Intime India Pvt Ltd

AGM Date (Month) : Jul
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 543233
Book Closure Date (Month) :
BSE Group : B
ISIN : INE03YM01018

FAQ’s on Chemcon Speciality Chemicals Ltd Shares

You can buy Chemcon Speciality Chemicals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Chemcon Speciality Chemicals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Oct 03, 2023 03:53 PM the closing price of Chemcon Speciality Chemicals Ltd was ₹ 281.05.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Oct 03, 2023 03:53 PM, the market cap of Chemcon Speciality Chemicals Ltd stood at ₹ 1,029.51.

The latest PE ratio of Chemcon Speciality Chemicals Ltd as of Oct 03, 2023 03:53 PM is 28.99

The latest PB ratio of Chemcon Speciality Chemicals Ltd as of Oct 03, 2023 03:53 PM is 0.44

The 52-week high of Chemcon Speciality Chemicals Ltd is ₹ 477.95 while the 52-week low is ₹ 221.00

Download Our App

market app
market app